Biofrontera Inc. ( BFRI) - Key Metrics
BFRI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.47 | $0.48 | -$0.20 | -$0.20 |
| 2025Q3 | $0.65 | -$0.62 | -$0.35 | -$0.35 |
| 2025Q2 | $0.97 | -$0.57 | -$0.33 | -$0.33 |
| 2025Q1 | $1.56 | -$0.76 | -$0.75 | -$0.75 |
BFRI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 0.29 |
| 2025Q3 | ? | -0.40 |
| 2025Q2 | ? | -0.31 |
| 2025Q1 | ? | -0.26 |
BFRI
Price: $1
52 week price:
Earnings Per Share: -0.98 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 345400
Market Capitalization: 9.6 million